VKTX · Viking Therapeutics, Inc. · Documents
$24.40
-1.43 (-5.54%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$2.85B
Shares
116.65M
Volume · Oct 23
4.68M
Avg daily vol (3M)
4.59M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-28 | 2026-09-23 | |
| 8-K | — | 2026-09-22 | — | |
| S-3ASR | — | 2026-07-30 | — | |
| 8-K | — | 2026-07-29 | — | |
| 10-Q | — | 2026-07-29 | 2026-06-30 | |
| 8-K | — | 2026-05-26 | 2026-05-19 | |
| 10-Q | — | 2026-04-30 | 2026-03-31 | |
| 8-K | — | 2026-04-29 | — | |
| ARS | — | 2026-04-01 | 2025-12-31 | |
| DEF 14A | — | 2026-04-01 | 2026-05-19 | |
| DEFA14A | — | 2026-04-01 | — | |
| 8-K | — | 2026-02-11 | — | |
| 10-K | — | 2026-02-11 | 2025-12-31 | |
| 10-Q | — | 2025-10-23 | 2025-09-30 | |
| 8-K | — | 2025-10-22 | — | |
| 8-K | — | 2025-08-19 | — | |
| 8-K | — | 2025-07-23 | — | |
| 10-Q | — | 2025-07-23 | 2025-06-30 | |
| 8-K | — | 2025-05-27 | 2025-05-20 | |
| 10-Q | — | 2025-04-24 | 2025-03-31 | |
| 8-K | — | 2025-04-23 | 2025-04-18 | |
| 8-K | — | 2025-04-23 | — | |
| DEFA14A | — | 2025-04-23 | — | |
| DEFR14A | — | 2025-04-23 | — | |
| DEF 14A | — | 2025-04-08 | 2025-05-20 | |
| ARS | — | 2025-04-08 | 2024-12-31 | |
| DEFA14A | — | 2025-04-08 | — | |
| 8-K | — | 2025-03-11 | 2025-03-10 | |
| 10-K | — | 2025-02-26 | 2024-12-31 | |
| 8-K | — | 2025-02-05 | — | |
| 8-K | — | 2024-11-04 | — | |
| 10-Q | — | 2024-10-23 | 2024-09-30 | |
| 8-K | — | 2024-10-23 | — | |
| 10-Q | — | 2024-07-24 | 2024-06-30 | |
| 8-K | — | 2024-07-24 | — | |
| 8-K | — | 2024-06-04 | — | |
| 8-K | — | 2024-05-23 | 2024-05-21 | |
| 10-Q | — | 2024-04-25 | 2024-03-31 | |
| 8-K | — | 2024-04-24 | — | |
| DEFA14A | — | 2024-04-05 | — | |
| ARS | — | 2024-04-05 | 2023-12-31 | |
| DEF 14A | — | 2024-04-05 | 2024-05-21 | |
| 8-K | — | 2024-03-26 | — | |
| 8-K | — | 2024-03-04 | — | |
| 8-K | — | 2024-03-01 | 2024-02-28 | |
| 8-K | — | 2024-02-27 | — | |
| 10-K | — | 2024-02-07 | 2023-12-31 | |
| 8-K | — | 2024-02-07 | — | |
| 8-K | — | 2023-10-25 | — | |
| 10-Q | — | 2023-10-25 | 2023-09-30 |
Showing 1–50 of 104 filings
Key facts
CIK
1607678
CUSIP
92686J106
13F (30d)
71 filings
71 filers
Visit website
Investor relations